Illumina and NVIDIA Just Dropped a Genomics Bombshell. Khac Phu Nguyen . Mon, Jan 13, 2025, ... New U.S. export rules on AI chips are drawing sharp criticism from the company, ...

Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for ...

At the start, there was a kind of “heads you lose, tails I win” kind of logic about Illumina’s decision to close the Grail purchase when European and U.S. regulators said they wanted to ...

Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s ...

Illumina spun off GRAIL in 2016 and then repurchased it in September 2020. It closed on the deal, then valued at $8 billion, in August 2021 before getting regulatory approval.

Illumina introduced gene-sequencing machines that it says can more-than-double capacity and slash the cost of sequencing, as it faces competition and price pressures.

Illumina stock reversed higher Tuesday, though China signaled it would ban the importation of the company's gene-mapping products as part of an escalating tariffs battle with President Donald Trump.

It's been a good week for Illumina, Inc. (NASDAQ:ILMN) shareholders, because the company has just released its latest first-quarter results, and the shares gained 4.3% to US$81.57. Revenues were ...

Illumina Inc. ILMN said Monday that activist investor Carl Icahn’s board nominees are “unqualified,” urging shareholders to reject all three of Icahn’s nominees and instead support its ...